Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 8

Submit an article Journal homepage

Open access

2,783

Views

CrossRef citations to date

Altmetric

Research Paper

Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations

Christine JuergensPfizer Vaccine Clinical Research and Development, Pfizer Pharma GmbH, Berlin, GermanyCorrespondence[email protected]

James TrammelBiostatistics, Syneos Health, Stonewall, LA, USA

Yasuko ShojiPfizer Vaccine Clinical Research and Development, Tokyo, Japan

Scott PattersonPfizer Vaccines Clinical Research & Development, Collegeville, PA, USA

Wendy WatsonPfizer Vaccines Clinical Research & Development, Collegeville, PA, USA

Chris WebberPfizer Vaccines Clinical Research & Development, Pearl River, NY, USA

William C. GruberPfizer Vaccines Clinical Research & Development, Pearl River, NY, USA

Daniel A. ScottPfizer Vaccines Clinical Research & Development, Collegeville, PA, USA

Beate Schmoele-ThomaPfizer Vaccine Clinical Research and Development, Pfizer Pharma GmbH, Berlin, Germany

http://orcid.org/0000-0003-4632-357X

show all

Pages 1948-1956 | Received 24 Oct 2017, Accepted 12 Mar 2018, Published online: 13 Apr 2018

Cite this article
https://doi.org/10.1080/21645515.2018.1452576
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson & Philipp Oster. (2022) Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age. Human Vaccines & Immunotherapeutics 18:6.
Read now

Federico Martinón-Torres, Isabelle Bertrand-Gerentes & Philipp Oster. (2021) A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines 20:9, pages 1123-1146.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references